Sertraline

Overview

Sertraline is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat major depressive disorder, anxiety and certain types of phobia. It functions by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

API suppliers (22)

Suppliers of Sertraline backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• RL FINE CHEM PVT LTD2 active DMF
• Endo PharmaceuticalsUnited States2 active DMF
• APITORIA PHARMA PRIVATE LTDIndia2 active DMF
• Hetero Drugs LimitedIndia2 active DMF
• MATRIX PHARMACORP PRIVATE LTD2 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Lupin LimitedIndia1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• Lupin LimitedIndia1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• WANBURY LTD1 active DMF
• Lupin LimitedIndia1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• WANBURY LTD1 active DMF
• Cipla USA, Inc.USA
• MOEHS IBERICA SLSpain
• Pharmaron Beijing Co., Ltd.China
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly
• RANBAXY LABORATORIES LTD

Patent & exclusivity (US)

Per the FDA Orange Book (56 approved US products), the latest listed US patent on Sertraline expires — and exclusivity 18 Jan 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas